Abstract
Introduction: Papillary thyroid carcinoma is the most common endocrine malignancy and the most common type of thyroid cancer, accounting for approximately 85% of all thyroid cancer cases. It usually has a favorable course, with the 10-year survival rate exceeding 90%. However, the literature reports a recurrence rate of 7–23% after initial surgical treatment. It is important to consider medical treatment policies for this recurrence. Methods: In this study, we examined the risk factors for the recurrence of papillary thyroid carcinoma. We treated 274 patients with thyroid papillary carcinoma at our hospital between 2009 and 2018. Results: Recurrence occurred in 20 cases (7.3%). Lympho-vascular invasion and lateral cervical lymph node metastasis made significant independent contributions. Conclusion: The selection of the surgical mode should be based on the recurrence and after comprehensive consideration of the clinical features.
References
1.
Siegel
RL
, Miller
KD
, Jemal
A
. Cancer statistics, 2017
. CA Cancer J Clin
. 2017
;67
(1
):7
–30
.2.
Ito
Y
, Kihara
M
, Takamura
Y
, Kobayashi
K
, Miya
A
, Hirokawa
M
, . Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years
. Endocr J
. 2012
;59
(7
):539
–45
.3.
Cancer Genome Atlas Research Network
, Akbani
R
, Aksoy
BA
, Ally
A
, Arachchi
H
, Asa
SL
. Integrated genomic characterization of papillary thyroid carcinoma
. Cell
. 2014
;159
(3
):676
–90
.4.
Malterling
RR
, Andersson
RE
, Falkmer
S
, Falkmer
U
, Nilehn
E
, Jarhult
J
. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life
. Acta Oncol
. 2010
;49
(4
):454
–9
.5.
Markovina
S
, Grigsby
PW
, Schwarz
JK
, DeWees
T
, Moley
JF
, Siegel
BA
, . Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence
. Thyroid
. 2014
;24
(7
):1121
–6
.6.
Popadich
A
, Levin
O
, Lee
JC
, Smooke-Praw
S
, Ro
K
, Fazel
M
, . A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer
. Surgery
. 2011
;150
(6
):1048
–57
.7.
Hartl
DM
, Mamelle
E
, Borget
I
, Leboulleux
S
, Mirghani
H
, Schlumberger
M
. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma
. World J Surg
. 2013
;37
(8
):1951
–8
.8.
Guo
K
, Wang
Z
. Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis
. Int J Clin Exp Pathol
. 2014
;7
(9
):5393
–403
.9.
Ito
Y
, Higashiyama
T
, Takamura
Y
, Miya
A
, Kobayashi
K
, Matsuzuka
F
, . Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection
. World J Surg
. 2007
;31
(11
):2085
–91
.10.
Baek
SK
, Jung
KY
, Kang
SM
, Kwon
SY
, Woo
JS
, Cho
SH
, . Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma
. Thyroid
. 2010
;20
(2
):147
–52
.11.
Bilimoria
KY
, Bentrem
DJ
, Ko
CY
, Stewart
AK
, Winchester
DP
, Talamonti
MS
, . Extent of surgery affects survival for papillary thyroid cancer
. Ann Surg
. 2007
;246
(3
):375
–81; discussion 381–4
.12.
de Meer
SGA
, Dauwan
M
, de Keizer
B
, Valk
GD
, Borel Rinkes
IHM
, Vriens
MR
. Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer
. World J Surg
. 2012
;36
(6
):1262
–7
.13.
Lin
JD
, Huang
MJ
, Juang
JH
, Chao
TC
, Huang
BY
, Chen
KW
, . Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases
. Thyroid
. 1999
;9
(12
):1227
–35
.14.
Tanaka
K
, Sonoo
H
, Hirono
M
, Ohkubo
S
, Nomura
T
, Ikeda
M
, . Retrospective analysis of predictive factors for recurrence after curatively resected papillary thyroid carcinoma
. Surg Today
. 2005
;35
(9
):714
–9
.15.
Lee
CW
, Roh
JL
, Gong
G
, Cho
KJ
, Choi
SH
, Nam
SY
, . Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck
. Ann Surg Oncol
. 2015
;22
(1
):117
–24
.16.
Ito
Y
, Kudo
T
, Kobayashi
K
, Miya
A
, Ichihara
K
, Miyauchi
A
. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5, 768 patients with average 10-year follow-up
. World J Surg
. 2012
;36
(6
):1274
–8
.17.
Pacini
F
, Schlumberger
M
, Dralle
H
, Elisei
R
, Smit
JWA
, Wiersinga
W
. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
. Eur J Endocrinol
. 2006
;154
(6
):787
–803
.18.
Leboulleux
S
, Rubino
C
, Baudin
E
, Caillou
B
, Hartl
DM
, Bidart
JM
, . Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis
. J Clin Endocrinol Metab
. 2005
;90
(10
):5723
–9
.19.
Zetoune
T
, Keutgen
X
, Buitrago
D
, Aldailami
H
, Shao
H
, Mazumdar
M
, . Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis
. Ann Surg Oncol
. 2010
;17
(12
):3287
–93
.20.
Barczyński
M
, Konturek
A
, Stopa
M
, Nowak
W
. Prophylactic central neck dissection for papillary thyroid cancer
. Br J Surg
. 2013
;100
(3
):410
–8
.21.
Moreno
MA
, Edeiken-Monroe
BS
, Siegel
ER
, Sherman
SI
, Clayman
GL
. In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival
. Thyroid
. 2012
;22
(4
):347
–55
.22.
Falvo
L
, Catania
A
, D’Andrea
V
, Marzullo
A
, Giustiniani
MC
, De Antoni
E
. Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma
. Ann Surg
. 2005
;241
(4
):640
–6
.© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.
